MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/pm/pnab338

Медицинская библиотека · Pain medicine (Malden, Mass.) · 2022

Research Recommendations Following the Discovery of Pain Sensitizing IgG Autoantibodies in Fibromyalgia Syndrome.

Goebel Andreas, Andersson David, Barker Chris, Basu Neil, Bullock Craig, Bevan Stuart, Bashford-Rogers Rachael J M, Choy Ernest, Clauw David, Dulake Debra, Dulake Richard, Flor Herta, Glanvill Marcia, Helyes Zsuzsanna, Irani Sarosh, Kosek Eva, Laird Jennifer, MacFarlane Gary, McCullough Hayley, Marshall Andrew, Moots Robert, Perrot Serge, Shenker Nick, Sher Emanuele, Sommer Claudia, Svensson Camilla I, Williams Amanda, Wood Geoff, Dorris Emma R

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Fibromyalgia syndrome (FMS) is the most common chronic widespread pain condition in rheumatology. Until recently, no clear pathophysiological mechanism for fibromyalgia had been established, resulting in management challenges. Recent research has indicated that serum immunoglobulin Gs (IgGs) may play a role in FMS. We undertook a research prioritisation exercise to identify the most pertinent research approaches that may lead to clinically implementable outputs.

METHODS

Research priority setting was conducted in five phases: situation analysis; design; expert group consultation; interim recommendations; consultation and revision. A dialogue model was used, and an international multi-stakeholder expert group was invited. Clinical, patient, industry, funder, and scientific expertise was represented throughout. Recommendation-consensus was determined via a voluntary closed eSurvey. Reporting guideline for priority setting of health research were employed to support implementation and maximise impact.

RESULTS

Arising from the expert group consultation (n = 29 participants), 39 interim recommendations were defined. A response rate of 81.5% was achieved in the consensus survey. Six recommendations were identified as high priority- and 15 as medium level priority. The recommendations range from aspects of fibromyalgia features that should be considered in future autoantibody research, to specific immunological investigations, suggestions for trial design in FMS, and therapeutic interventions that should be assessed in trials.

CONCLUSIONS

By applying the principles of strategic priority setting we directed research towards that which is implementable, thereby expediating the benefit to the FMS patient population. These recommendations are intended for patients, international professionals and grant-giving bodies concerned with research into causes and management of patients with fibromyalgia syndrome.

Для цитирования: Goebel Andreas, Andersson David, Barker Chris, Basu Neil, Bullock Craig, Bevan Stuart, Bashford-Rogers Rachael J M, Choy Ernest, Clauw David, Dulake Debra, Dulake Richard, Flor Herta, Glanvill Marcia, Helyes Zsuzsanna, Irani Sarosh, Kosek Eva, Laird Jennifer, MacFarlane Gary, McCullough Hayley, Marshall Andrew, Moots Robert, Perrot Serge, Shenker Nick, Sher Emanuele, Sommer Claudia, Svensson Camilla I, Williams Amanda, Wood Geoff, Dorris Emma R. Research Recommendations Following the Discovery of Pain Sensitizing IgG Autoantibodies in Fibromyalgia Syndrome.. Pain medicine (Malden, Mass.). 2022. DOI: 10.1093/pm/pnab338.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.